Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Feb 25 | PROK ProKidney | Class A Ordinary Shares | Conversion | Acquire C | Yes | No | 0 | 675,234 | 0.00 | 675,234 |
4 Feb 25 | PROK ProKidney | Class A Ordinary Shares | Conversion | Acquire C | No | No | 0 | 81,928 | 0.00 | 81,928 |
4 Feb 25 | PROK ProKidney | Common Units in ProKidney LP Class A Ordinary Shares | Conversion | Dispose C | Yes | No | 0 | 675,234 | 0.00 | 675,235 |
4 Feb 25 | PROK ProKidney | Class B Ordinary Shares Class A Ordinary Shares | Conversion | Dispose C | Yes | No | 0 | 675,234 | 0.00 | 675,235 |
4 Feb 25 | PROK ProKidney | Common Units in ProKidney LP Class A Ordinary Shares | Conversion | Dispose C | No | No | 0 | 81,928 | 0.00 | 81,929 |
4 Feb 25 | PROK ProKidney | Class B Ordinary Shares Class A Ordinary Shares | Conversion | Dispose C | No | No | 0 | 81,928 | 0.00 | 81,929 |
3 Oct 24 | KALV KalVista Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 11.54 | 10,000 | 115.40 k | 10,000 |
30 May 24 | PROK ProKidney | Director stock option Class A Ordinary Shares | Grant | Acquire A | No | No | 4.2 | 62,558 | 262.74 k | 62,558 |
26 Sep 23 | KALV KalVista Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 10.08 | 10,000 | 100.80 k | 10,000 |